BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Avagimyan AA, Mkrtchyan LH, Gevorkyan AA, Kononchuk NB, Kakturskiy LV, Djndoyan ZT. Relationship between Chemotherapy and Atrial Fibrillation: Clinical Case. Racionalʹnaâ farmakoterapiâ v kardiologii 2021;17:785-91. [DOI: 10.20996/1819-6446-2021-10-17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Avagimyan AA, Kakturskiy LV. Trimetazidine as a modifier of doxorubicin+cyclophosphamideinduced hyperdyslipidemia. SJCEM 2022;37:105-111. [DOI: 10.29001/2073-8552-2022-37-2-105-111] [Reference Citation Analysis]
2 Avagimyan AA. Influence of trimetazidine on myocardium energy balance during chemotherapy with doxorubicin and cyclophosphamide. Sibirskij nauchnyj medicinskij zhurnal 2022;42:41-46. [DOI: 10.18699/ssmj20220304] [Reference Citation Analysis]
3 Avagimyan A, Kaktursky L. CARDIOTOXICITY OF CYCLOPHOSPHAMIDE: CURRENT STATE OF THE PROBLEM. jecm 2022. [DOI: 10.52340/jecm.2022.03.14] [Reference Citation Analysis]
4 Avagimyan A. THE PATHOPHYSIOLOGICAL BASIS OF DIABETIC CARDIOMYOPATHY DEVELOPMENT. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
5 Amiodarone/antineoplastics/sotalol. Reactions Weekly 2022;1888:32-32. [DOI: 10.1007/s40278-022-08374-6] [Reference Citation Analysis]